MeiraGTx Holdings (MGTX) Net Equity Issued and Repurchased (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Net Equity Issued and Repurchased of $5.2 million for Q4 2025, down 5.04% on a QoQ basis from $5.4 million in Q2 2025, and up 21.25% year-over-year from $4.3 million in Q4 2024.
MeiraGTx Holdings (MGTX) Net Equity Issued and Repurchased (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at $5.2 million for Q4 2025.
- Quarterly Net Equity Issued and Repurchased rose 21.25% year-over-year to $5.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.1 million (down 74.62% YoY) and the FY2025 annual result came in at $15.1 million, down 74.62% from the prior year.
- Net Equity Issued and Repurchased was $5.2 million for Q4 2025 at MeiraGTx Holdings, down from $5.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $100.0 million in Q4 2023 and bottomed at -$2.8 million in Q1 2022.
- A 4-year average of $19.1 million and a median of $4.5 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased plunged 95.74% — and 2025, when it surged 237.03%.
- MeiraGTx Holdings' Net Equity Issued and Repurchased stood at -$2.8 million in 2022, then surged by 3704.9% to $100.0 million in 2023, then plunged by 95.74% to $4.3 million in 2024, then grew by 21.25% to $5.2 million in 2025.
- Business Quant data shows MGTX's Net Equity Issued and Repurchased at $5.2 million in Q4 2025, $5.4 million in Q2 2025, and $4.5 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 5.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.16 Mn |
| Dec 31, 2025 | 5.16 Mn |
| Jun 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | 5.43 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Sep 30, 2024 | 51.94 Mn |
| Sep 30, 2024 | 51.94 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Mar 31, 2022 | -2.77 Mn |
| Mar 31, 2022 | -2.77 Mn |
| Dec 31, 2020 | 9.60 Mn |
| Dec 31, 2020 | 9.60 Mn |